| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/147323001003800402 |
| P8608 | Fatcat ID | release_7egbbc6igvbafho73osj54p3ji |
| P953 | full work available at URL | http://imr.sagepub.com/content/38/4/1213.full.pdf |
| http://journals.sagepub.com/doi/pdf/10.1177/147323001003800402 | ||
| P698 | PubMed publication ID | 20925993 |
| P5875 | ResearchGate publication ID | 47356833 |
| P50 | author | Peter C. Taylor | Q60325744 |
| Juan J Gómez-Reino | Q88208653 | ||
| P2093 | author name string | E. Eberhardt | |
| F. Wolfe | |||
| A. Kavanaugh | |||
| R. Johnstone | |||
| S. Schwartzman | |||
| B. Manger | |||
| J. Alvaro-Gracia | |||
| N. Furfaro | |||
| P2860 | cites work | The Journal of Rheumatology | Q7743623 |
| Living with rheumatoid arthritis: a phenomenological exploration | Q71286436 | ||
| Including patient preferences in nurses' assessment of older patients | Q74394307 | ||
| Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority | Q74714748 | ||
| Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis | Q84172541 | ||
| Disability and depression in rheumatoid arthritis. A multi-trait, multi-method investigation | Q93519284 | ||
| The Journal of rheumatology. Supplement | Q27711737 | ||
| Rheumatology grand rounds at rush: patient self-report data are key to better patient care | Q31067030 | ||
| Are quality of life measures patient centred? | Q34270312 | ||
| Values for function in rheumatoid arthritis: patients, professionals, and public. | Q35549789 | ||
| Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis | Q36244727 | ||
| Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study | Q40360283 | ||
| Women with established rheumatoid arthritis perceive pain as the predominant impairment of health status | Q40590333 | ||
| Patients as partners in managing chronic disease. Partnership is a prerequisite for effective and efficient health care | Q42766294 | ||
| Remission in rheumatoid arthritis: physician and patient perspectives | Q44996426 | ||
| Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry | Q46879731 | ||
| Rheumatology patient and physician concordance with respect to important health and symptom status outcomes | Q47575008 | ||
| Patients' perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored | Q48530932 | ||
| Predictors of subjective fatigue among individuals with rheumatoid arthritis. | Q50850170 | ||
| Self-efficacy and health status in rheumatoid arthritis: a two-year longitudinal observational study. | Q51967604 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| rheumatoid arthritis | Q187255 | ||
| pain management | Q621261 | ||
| P304 | page(s) | 1213-1224 | |
| P577 | publication date | 2010-07-01 | |
| P1433 | published in | Journal of International Medical Research | Q15758331 |
| P1476 | title | Patient perceptions concerning pain management in the treatment of rheumatoid arthritis | |
| Patient Perceptions concerning Pain Management in the Treatment of Rheumatoid Arthritis | |||
| P478 | volume | 38 |
| Q48154527 | A critical evaluation of validity and utility of translational imaging in pain and analgesia: Utilizing functional imaging to enhance the process |
| Q92854346 | Achieving Pain Control in Rheumatoid Arthritis with Baricitinib or Adalimumab Plus Methotrexate: Results from the RA-BEAM Trial |
| Q35783653 | An outsourced health-enhancing physical activity programme for people with rheumatoid arthritis: exploration of adherence and response |
| Q33859026 | Animal models of rheumatoid pain: experimental systems and insights. |
| Q61799672 | Anti-citrullinated protein antibodies are associated with osteopenia but not with pain at diagnosis of rheumatoid arthritis: data from the BARFOT cohort |
| Q57167038 | Associations between fatigue and physical capacity in people moderately affected by rheumatoid arthritis |
| Q48241266 | Bis(phenylimidazoselenazolyl) diselenide elicits antinociceptive effect by modulating myeloperoxidase activity, NOx and NFkB levels in the collagen-induced arthritis mouse model. |
| Q35234755 | CCR1 plays a critical role in modulating pain through hematopoietic and non-hematopoietic cells |
| Q52807047 | Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritis. |
| Q34573121 | Can the painDETECT Questionnaire score and MRI help predict treatment outcome in rheumatoid arthritis: protocol for the Frederiksberg hospital's Rheumatoid Arthritis, pain assessment and Medical Evaluation (FRAME-cohort) study |
| Q92732365 | Cartilage-binding antibodies induce pain through immune complex-mediated activation of neurons |
| Q54294566 | Collagen antibody-induced arthritis evokes persistent pain with spinal glial involvement and transient prostaglandin dependency. |
| Q64109275 | Combining naproxen and a dual amylin and calcitonin receptor agonist improves pain and structural outcomes in the collagen-induced arthritis rat model |
| Q26778129 | Current status and future directions of botulinum neurotoxins for targeting pain processing |
| Q36725890 | Differences in activity limitation, pain intensity, and global health in patients with rheumatoid arthritis in Sweden and the USA: a 5-year follow-up |
| Q36458539 | Different phosphoinositide 3-kinase isoforms mediate carrageenan nociception and inflammation |
| Q50426470 | Divergent roles of immune cells and their mediators in pain |
| Q93156337 | Effect of Baricitinib and Adalimumab in Reducing Pain and Improving Function in Patients with Rheumatoid Arthritis in Low Disease Activity: Exploratory Analyses from RA-BEAM |
| Q35750556 | Evaluation of a disease specific rheumatoid arthritis self-management education program, a single group repeated measures study |
| Q61809484 | Evaluation of alexithymia in patients affected by rheumatoid arthritis and psoriatic arthritis: A cross-sectional study |
| Q40009047 | Experiences of Patients With Rheumatoid Arthritis: A Qualitative Study |
| Q36102004 | Factors predicting pain and early discontinuation of tumour necrosis factor-α-inhibitors in people with rheumatoid arthritis: results from the British society for rheumatology biologics register |
| Q35317779 | Fear-avoidance beliefs about physical activity in adults with rheumatoid arthritis. |
| Q37620064 | Focus group interviews reveal reasons for differences in the perception of disease activity in rheumatoid arthritis |
| Q37096038 | IL4-10 Fusion Protein Is a Novel Drug to Treat Persistent Inflammatory Pain. |
| Q41607103 | Interleukin-17A is involved in mechanical hyperalgesia but not in the severity of murine antigen-induced arthritis |
| Q36685781 | Intrinsic Brain Connectivity in Chronic Pain: A Resting-State fMRI Study in Patients with Rheumatoid Arthritis |
| Q53309369 | Long-Lasting Activation of the Transcription Factor CREB in Sensory Neurons by Interleukin-1β During Antigen-Induced Arthritis in Rats: A Mechanism of Persistent Arthritis Pain? |
| Q92037239 | Neuropathic-like pain in psoriatic arthritis: evidence of abnormal pain processing |
| Q31059883 | Non-nociceptive pain in rheumatoid arthritis is frequent and affects disease activity estimation: cross-sectional data from the FRAME study. |
| Q48576983 | Pain as an important predictor of psychosocial health in patients with rheumatoid arthritis |
| Q36843390 | Pain experience in children with juvenile idiopathic arthritis treated with anti-TNF agents compared to non-biologic standard treatment |
| Q38056432 | Pain in rheumatoid arthritis |
| Q38810372 | Pain in rheumatoid arthritis: models and mechanisms. |
| Q24235180 | Pain management for rheumatoid arthritis and cardiovascular or renal co-morbidity |
| Q24235971 | Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity |
| Q47305060 | Pain management: Opioids for RA: a clinical dilemma |
| Q35557868 | Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study |
| Q36323464 | Pain, depressive symptoms and medication in German patients with rheumatoid arthritis-results from the linking patient-reported outcomes with claims data for health services research in rheumatology (PROCLAIR) study. |
| Q50951381 | Parents' preferences for drug treatments in juvenile idiopathic arthritis: a discrete choice experiment. |
| Q39492734 | Predictors of pain for patients with early inflammatory polyarthritis |
| Q37358286 | Prioritizing the patient: optimizing therapy in rheumatoid arthritis. Results of a patient questionnaire in northern Germany |
| Q37456609 | Remaining Pain in Early Rheumatoid Arthritis Patients Treated With Methotrexate |
| Q36245918 | Sensory and sympathetic nerve fibers undergo sprouting and neuroma formation in the painful arthritic joint of geriatric mice |
| Q37517356 | Temporal summation of pain and ultrasound Doppler activity as predictors of treatment response in patients with rheumatoid arthritis: protocol for the Frederiksberg hospitals Rheumatoid Arthritis, pain assessment and Medical Evaluation (FRAME-cohort |
| Q36992406 | The Emerging Role of Spinal Dynorphin in Chronic Pain: A Therapeutic Perspective |
| Q98720322 | The burden of pain in rheumatoid arthritis: impact of disease activity and psychological factors |
| Q99710881 | The neuropathic phenotype of the K/BxN transgenic mouse with spontaneous arthritis: pain, nerve sprouting and joint remodeling |
| Q24288817 | The search for novel analgesics: targets and mechanisms |
| Q85763352 | Towards evidence-based hand exercises in rheumatoid arthritis |
| Q57488699 | Use of steroid and nonsteroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review protocol |
| Q60061929 | VEGFR2 promotes central endothelial activation and the spread of pain in inflammatory arthritis |
Search more.